Literature DB >> 33017466

Whole-genome sequencing reveals potent therapeutic strategy for monomorphic epitheliotropic intestinal T-cell lymphoma.

Dachuan Huang1,2, Jing Quan Lim1,2, Daryl Ming Zhe Cheah1, Khalilatul Hanisah Binte Mohd Kahliab1, Yurike Laurensia1, Jane Wan Lu Pang1, Esther Kam Yin Wong1, Burton Kuan Hui Chia1, Jasmine Goh3, Xiyun Zhang3, Jason Yongsheng Chan4, Edward Kai-Hua Chow3, Soo Yong Tan5, Soon Thye Lim2,4,6, Choon Kiat Ong1,2,7.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33017466      PMCID： PMC7556141          DOI： 10.1182/bloodadvances.2020001782

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  25 in total

1.  Linking double-stranded DNA breaks to the recombination activating gene complex directs repair to the nonhomologous end-joining pathway.

Authors:  Xiaoping Cui; Katheryn Meek
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-15       Impact factor: 11.205

Review 2.  Recent advances in intestinal lymphomas.

Authors:  Periklis G Foukas; Laurence de Leval
Journal:  Histopathology       Date:  2015-01       Impact factor: 5.087

3.  Enteropathy-associated T-cell lymphoma--a clinicopathologic and array comparative genomic hybridization study.

Authors:  Young Hyeh Ko; Sivasundaram Karnan; Kyeong Mee Kim; Cheol Keun Park; Eun Suk Kang; Young Ho Kim; Won Ki Kang; Seok Jin Kim; Won Seog Kim; Woo Yong Lee; Ho Kyung Chun; Masao Seto
Journal:  Hum Pathol       Date:  2010-04-18       Impact factor: 3.466

4.  Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma.

Authors:  Ghee Chong Koo; Soo Yong Tan; Tiffany Tang; Song Ling Poon; George E Allen; Leonard Tan; Soo Ching Chong; Whee Sze Ong; Kevin Tay; Miriam Tao; Richard Quek; Susan Loong; Kheng-Wei Yeoh; Swee Peng Yap; Kuo Ann Lee; Lay Cheng Lim; Daryl Tan; Christopher Goh; Ioana Cutcutache; Willie Yu; Cedric Chuan Young Ng; Vikneswari Rajasegaran; Hong Lee Heng; Anna Gan; Choon Kiat Ong; Steve Rozen; Patrick Tan; Bin Tean Teh; Soon Thye Lim
Journal:  Cancer Discov       Date:  2012-06-15       Impact factor: 39.397

5.  Identification of a homozygous JAK3 V674A mutation caused by acquired uniparental disomy in a relapsed early T-cell precursor ALL patient.

Authors:  Sachiko Kawashima-Goto; Toshihiko Imamura; Masafumi Seki; Motohiro Kato; Kenichi Yoshida; Atsuya Sugimoto; Daisuke Kaneda; Atsushi Fujiki; Mitsuru Miyachi; Takuya Nakatani; Shinya Osone; Hiroyuki Ishida; Tomohiko Taki; Junko Takita; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Satoru Miyano; Seishi Ogawa; Hajime Hosoi
Journal:  Int J Hematol       Date:  2014-11-28       Impact factor: 2.490

6.  Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8αα phenotype.

Authors:  S-Y Tan; S-S Chuang; T Tang; L Tan; Y-H Ko; K-L Chuah; S-B Ng; W-J Chng; K Gatter; F Loong; Y-H Liu; P Hosking; P-L Cheah; B-T Teh; K Tay; M Koh; S-T Lim
Journal:  Leukemia       Date:  2013-02-12       Impact factor: 11.528

7.  Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses.

Authors:  Bertrand Coiffier; Barbara Pro; H Miles Prince; Francine Foss; Lubomir Sokol; Matthew Greenwood; Dolores Caballero; Franck Morschhauser; Martin Wilhelm; Lauren Pinter-Brown; Swaminathan Padmanabhan Iyer; Andrei Shustov; Tina Nielsen; Jean Nichols; Julie Wolfson; Barbara Balser; Steven Horwitz
Journal:  J Hematol Oncol       Date:  2014-01-23       Impact factor: 17.388

8.  Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphoma.

Authors:  Lip Kun Tan; Edward K Chow; Anand D Jeyasekharan; Sanjay de Mel; Masturah B M Rashid; Xi Yun Zhang; Jasmine Goh; Chun Tsu Lee; Li Mei Poon; Esther H L Chan; Xin Liu; Wee Joo Chng; Yen Lin Chee; Joanne Lee; Yi Ching Yuen; Jing Quan Lim; Burton K H Chia; Yurike Laurensia; DaChuan Huang; Wan Lu Pang; Daryl Ming Zhe Cheah; Esther Kam Yin Wong; Choon Kiat Ong; Tiffany Tang; Soon Thye Lim; Siok Bian Ng; Soo Yong Tan; Hoi-Yin Loi
Journal:  Blood Cancer J       Date:  2020-01-27       Impact factor: 11.037

9.  Clock-like mutational processes in human somatic cells.

Authors:  Ludmil B Alexandrov; Philip H Jones; David C Wedge; Julian E Sale; Peter J Campbell; Serena Nik-Zainal; Michael R Stratton
Journal:  Nat Genet       Date:  2015-11-09       Impact factor: 38.330

10.  Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation.

Authors:  Sophia X Pfister; Enni Markkanen; Yanyan Jiang; Sovan Sarkar; Mick Woodcock; Giulia Orlando; Ioanna Mavrommati; Chen-Chun Pai; Lykourgos-Panagiotis Zalmas; Neele Drobnitzky; Grigory L Dianov; Clare Verrill; Valentine M Macaulay; Songmin Ying; Nicholas B La Thangue; Vincenzo D'Angiolella; Anderson J Ryan; Timothy C Humphrey
Journal:  Cancer Cell       Date:  2015-11-09       Impact factor: 31.743
View more
  2 in total

1.  Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitors.

Authors:  Jhin Jieh Lim; Lissa Hooi; Yock Young Dan; Glenn K Bonney; Lei Zhou; Pierce K-H Chow; Cheng Ean Chee; Tan Boon Toh; Edward K-H Chow
Journal:  J Exp Clin Cancer Res       Date:  2022-08-15

2.  Primary Gastrointestinal T/NK Cell Lymphoma.

Authors:  Eun Kyung Kim; Mi Jang; Woo Ick Yang; Sun Och Yoon
Journal:  Cancers (Basel)       Date:  2021-05-29       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.